The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M03 | Muscle relaxants | |
| 3 | M03B | Muscle relaxants, centrally acting agents | |
| 4 | M03BB | Oxazol, thiazine, and triazine derivatives |
| Code | Title | |
|---|---|---|
| M03BB02 | Chlormezanone | |
| M03BB03 | Chlorzoxazone | |
| M03BB52 | Chlormezanone, combinations excl. psycholeptics | |
| M03BB53 | Chlorzoxazone, combinations excl. psycholeptics | |
| M03BB72 | Chlormezanone, combinations with psycholeptics | |
| M03BB73 | Chlorzoxazone, combinations with psycholeptics |
| Active Ingredient | Description | |
|---|---|---|
| Chlormezanone |
|
|
| Chlorzoxazone |
Chlorzoxazone is a centrally-acting agent for painful musculoskeletal conditions. Data available from animal experiments as well as human study indicate that chlorzoxazone acts primarily at the level of the spinal cord and subcortical areas of the brain where it inhibits multisynaptic reflex arcs involved in producing and maintaining skeletal muscle spasm of varied etiology. |
